LEVERKUSEN, Germany & ST. LOUIS–(BUSINESS WIRE)–“We appreciate the Court’s careful consideration of FIFRA’s Uniformity language and how its federal preemption provision applies to state-based label warnings. “We believe the U.S. Government and the Company made persuasive arguments that state-based warning claims ‘in addition to or different from’ warning labels approved by EPA under FIFRA, as … [Read more…]
OVERLAND PARK, Kan.–(BUSINESS WIRE)–#ArtificialIntelligence—Netsmart, an industry-leading technology platform company with a suite of solutions and services for community-based providers, announces its participation at the National Council for Mental Wellbeing 2026 Conference (NatCon26) taking place April 27-29 in Denver. Marking nearly two decades of collaboration with the National Council, Netsmart reinforces its long-standing commitment to its … [Read more…]
— SOLOSEC® (secnidazole) 2g Oral Granules is an FDA-Approved Single-Dose Oral Treatment for Bacterial Vaginosis and Trichomoniasis — SAN DIEGO–(BUSINESS WIRE)–$EVFM #BV–Women’s health innovator Evofem Biosciences, Inc. (OTCID: EVFM) (Evofem or the Company) today announced that it has entered into an exclusive Distribution Agreement with Clovis Davis Pharmaceuticals, LLC, a distributor of pharmaceutical and related … [Read more…]
The RESONATE early feasibility study will assess safety and viability of the wirelessly-powered XCS System in patients with treatment-resistant depression across eight leading medical institutions. HOUSTON–(BUSINESS WIRE)–Motif Neurotech, a brain-computer interface (BCI) company developing technologies for mental health, today announced that the U.S. Food and Drug Administration (FDA) has approved an Investigational Device Exemption (IDE) … [Read more…]
Organon stockholders to receive US$ 14.00 per share in cash The deal values Organon at EV of US$ 11.75 billion Combined Business leverages complementary portfolios and global scale for sustained long‑term value creation MUMBAI, India & JERSEY CITY, N.J.–(BUSINESS WIRE)–Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its … [Read more…]
Conference call will take place on Monday, April 27, 2026 at 8:00 am ET NEW HAVEN, Conn.–(BUSINESS WIRE)–Veradermics, Incorporated (NYSE: MANE), a dermatologist-founded, late-stage biopharmaceutical company focused on developing innovative therapeutics for pattern hair loss, today announced it will host an investor call and live webcast to review topline results from Part A of its … [Read more…]
84% Freedom From Shock and 59% Freedom From VT Recurrence in FULCRUM-VT Pivotal IDE Trial Meet Safety and Effectiveness Endpoints and Replicate CryoCure-VT Results First and Only Ablation Technology to Show Equivalent Effectiveness Across Ischemic and Non-Ischemic Cardiomyopathy All From Endocardial Approach LAGUNA HILLS, Calif.–(BUSINESS WIRE)–$ADGM #Arrhythmia–Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the … [Read more…]
For the first time, Eisen and NFL Network filmed on the St. Jude campus alongside patient families, staff and supporters, surrounded by the research hospital that his fundraising helps support MEMPHIS, Tenn.–(BUSINESS WIRE)–Rich Eisen, one of the most recognizable voices in sports media, brought his iconic “Run Rich Run” 40-yard dash to the campus of … [Read more…]
Multicenter results show sustained high durability and procedural efficiency, redefining positive expectations for catheter ablation in patients with atrial fibrillation HAYWARD, Calif.–(BUSINESS WIRE)–Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of novel nPulse™ technology using proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced late-breaking positive clinical data from its nPulse Cardiac Catheter System … [Read more…]
SYDNEY–(BUSINESS WIRE)–#AI–Integrant (proposed ticker: INGT) today announced the successful closure of its Series A capital raise, originally opened in April 2025. The round attracted strong investor interest, with responses described by the company as highly encouraging and reflective of growing confidence in its technology and strategic direction. Since initiating the Series A, Integrant has achieved … [Read more…]
